Cargando…
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
BACKGROUND: Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking. METHODS: We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults recruited between May 1 and November 2, 2020, without a pos...
Autores principales: | Talaei, Mohammad, Faustini, Sian, Holt, Hayley, Jolliffe, David A., Vivaldi, Giulia, Greenig, Matthew, Perdek, Natalia, Maltby, Sheena, Bigogno, Carola M., Symons, Jane, Davies, Gwyneth A., Lyons, Ronan A., Griffiths, Christopher J., Kee, Frank, Sheikh, Aziz, Richter, Alex G., Shaheen, Seif O., Martineau, Adrian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860623/ https://www.ncbi.nlm.nih.gov/pubmed/35189888 http://dx.doi.org/10.1186/s12916-022-02286-4 |
Ejemplares similares
-
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)
por: Jolliffe, David A., et al.
Publicado: (2022) -
Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination
por: Holt, Hayley, et al.
Publicado: (2023) -
Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
por: Jolliffe, David A, et al.
Publicado: (2022) -
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)
por: Vivaldi, Giulia, et al.
Publicado: (2022) -
Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)
por: Tydeman, Florence, et al.
Publicado: (2023)